Analyze Portfolio
Nasdaq · Healthcare

Precipio, Inc. (PRPO)

As-reported financials and recent SEC filings for Precipio, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue
$24.2M
Net income
$-363,000
Net margin
-1.5%
Diluted EPS
$-0.23
ROE
-2.5%
P/E (TTM)
Market cap
Debt / equity
0.0×

Income statement (as reported)

LineFY2025FY2025FY2023FY2022FY2021
Revenue$24.2M$18.6M$15.4M$9.8M$8.7M
Gross profit$10.9M$7.6M$6.2M$2.9M$2.2M
Operating income$-1.2M$-4.2M$-7.6M$-12.8M$-9.6M
Net income$-363,000$-4.3M$-5.9M$-12.2M$-8.5M
Diluted EPS$-0.23$-2.93$-4.51$-10.73$-7.60

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-06-15
View on EDGAR →
1442026-05-19
View on EDGAR →
10-Q2026-05-14
View on EDGAR →
8-K2026-05-06
View on EDGAR →
ARS2026-04-28
View on EDGAR →
DEFA14A2026-04-28
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Go deeper on PRPO

Search Precipio, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.